On December 6, the 8th Global Science & Technology Innovation Conference 2024 and the Awards Ceremony of the 2nd "Zhongzhilu" Yangtze River Delta High-Value Patent Operation Competition were grandly held in Shanghai. Neuboron Medtech Ltd. (hereinafter referred to as "Neuboron") and its subsidiary, Neuboron Shanghai Technologies Ltd., stood out among numerous outstanding projects with their patent project "Beam Shaping Body for Neutron Capture Therapy" and won the Silver Award.
BNCT is a cutting-edge cancer treatment technology developing rapidly worldwide. The award-winning patent project involves the beam shaping body—a core component of the BNCT treatment system. It is key to ensuring the quality of neutron beams and also one of the decisive factors for the success of BNCT treatment. This award further demonstrates the advancement and leadership of Neuboron's self-developed core patent technologies, and also affirms and encourages Neuboron's long-term commitment to technological innovation and intellectual property protection. In the future, Neuboron will continue to increase R&D investment, continuously enhance independent innovation capabilities, promote the transformation and application of more high-value patents, and contribute to the innovative development and application popularization of BNCT.
